J. Tchaicha

发表

Erratum: β8 integrin regulates neurogenesis and neurovascular homeostasis in the adult brain (Journal of Cell Science (2009) vol. 122 (1842-1851))

J. McCarty, A. Mobley, M. Hossain, 2009 .

β8 integrin regulates neurogenesis and neurovascular homeostasis in the adult brain

J. McCarty, M. Hossain, J. Tchaicha, 2009, Journal of Cell Science.

Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer

M. Loda, J. Kutok, S. Tyekucheva, 2018, Proceedings of the National Academy of Sciences.

The impact of the MYB-NFIB fusion proto-oncogene in vivo

P. Hammerman, Kwok-Kin Wong, R. Bronson, 2016, Oncotarget.

166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo

G. Helmlinger, J. Meulen, Sunandan Saha, 2021, Journal for ImmunoTherapy of Cancer.

Discovery and characterization of a novel aryl hydrocarbon receptor inhibitor, IK-175, and its inhibitory activity on tumor immune suppression.

M. Manfredi, J. Ecsedy, Alfredo C Castro, 2022, Molecular cancer therapeutics.

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer

Travis J Cohoon, Kwok-Kin Wong, J. Qi, 2013, Clinical Cancer Research.

Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.

Chandra Sekhar Pedamallu, Gad Getz, Kwok-Kin Wong, 2013, Cancer research.

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

J. Kutok, J. Wolchok, Sujata Sharma, 2016, Nature.

αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion

K. Aldape, F. Lang, J. McCarty, 2013, Molecular biology of the cell.

D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice

Travis J Cohoon, K. Ligon, Kwok-Kin Wong, 2014, Genes & development.

Inhibitor-Sensitive FGFR 2 and FGFR 3 Mutations in Lung Squamous Cell Carcinoma

Rachel G Liao, A. Sivachenko, G. Getz, 2013 .

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

Shohei Koyama, Kwok-Kin Wong, Hongbin Ji, 2014, Cancer cell.

Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.

Travis J Cohoon, D. Hayes, D. Root, 2013, Cancer discovery.

Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non–Small Cell Lung Cancer Cells

Kwok-Kin Wong, D. Kufe, E. Kikuchi, 2014, Clinical Cancer Research.

1 TARGETING THE ONCOGENIC MUC 1-C PROTEIN INHIBITS MUTANT EGFR-MEDIATED SIGNALING AND SURVIVAL IN NON-SMALL CELL LUNG CANCER CELLS

Kwok-Kin Wong, E. Kikuchi, H. Rajabi, 2014 .

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

J. Wolchok, T. Merghoub, L. F. Campesato, 2020, Nature Communications.

Cancer Therapy : Preclinical Ef fi cacy of BET Bromodomain Inhibition in Kras-Mutant Non – Small Cell Lung Cancer

Junqi, Travis J Cohoon, Kwok-Kin Wong, 2013 .

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.

Travis J Cohoon, M. Meyerson, D. Hayes, 2013, Cancer discovery.

Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.

F. Lang, J. McCarty, J. Tchaicha, 2011, Cancer research.

Microenvironment and Immunology Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by b 8 Integrin

F. Lang, J. McCarty, J. Tchaicha, 2011 .

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

M. Meyerson, P. Hammerman, Kwok-Kin Wong, 2014, Cancer research.

Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression

G. Fuller, G. Rao, F. Lang, 2017, Oncogene.

A Mosaic Mouse Model of Astrocytoma Identifies αvβ8 Integrin as an Essential Regulator of Tumor-Induced Angiogenesis

K. Aldape, J. McCarty, J. Tchaicha, 2010, Oncogene.

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.

M. Meyerson, M. Wilkerson, P. Jänne, 2013, Cancer discovery.

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

Rachel G Liao, M. Meyerson, P. Hammerman, 2014, Cancer research.